(Reuters) -MeiraGTx Holdings has signed a deal with Eli Lilly, potentially worth over $475 million, granting the pharma giant ...
Tenaya Therapeutics said on Friday the U.S. Food and Drug Administration has placed a clinical hold on its trial of an ...
Effective management of inherited retinal diseases requires a comprehensive approach to diagnosis and treatment, according to ...
9hon MSN
Nature vs. nurture: Sequencing study quantifies genetic influence on human traits and diseases
Genome sequencing has been used to determine how much genes influence human characteristics including height and weight, and ...
Centenary Institute researchers have uncovered new genetic causes of inherited heart conditions, providing families with vital answers to guide ...
1don MSN
Researchers use AI and genetics to identify early signs of a rare, life-threatening heart condition
At Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs of ...
With more than 250 peer-reviewed papers published in several high-impact journals, Katalin Susztak, MD, PhD, has opened the ...
Positive 3-month pediatric and 18-month adult clinical data from OPGx-LCA5 Phase 1/2 trial support the potential for restoring cone-mediated ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...
Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides the potential for an accelerated regulatory pathway ...
Scientists at Mayo Clinic have uncovered a rare genetic twist that challenges what we thought we knew about one of the world’s most common liver diseases.
Conference 2025, GENinCode the predictive genetics company focused on the prevention of cardiovascular disease ("CVD"), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback